Won-Keun Kim1,2,3, Johannes Blumenstein4, Christoph Liebetrau5,6, Andreas Rolf5,6, Luise Gaede4, Arnaud Van Linden7, Mani Arsalan7, Mirko Doss7, Jan G P Tijssen8, Christian W Hamm5,6, Thomas Walther7, Helge Möllmann4. 1. Department of Cardiology, Kerckhoff Heart Center, 61231, Bad Nauheim, Germany. w.kim@kerckhoff-klinik.de. 2. Department of Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany. w.kim@kerckhoff-klinik.de. 3. Department of Cardiology and Angiology, Justus-Liebig University of Giessen, Giessen, Germany. w.kim@kerckhoff-klinik.de. 4. Department of Internal Medicine and Cardiology, St. Johannes Hospital, Dortmund, Germany. 5. Department of Cardiology, Kerckhoff Heart Center, 61231, Bad Nauheim, Germany. 6. Department of Cardiology and Angiology, Justus-Liebig University of Giessen, Giessen, Germany. 7. Department of Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany. 8. Institute of Clinical Epidemiology and Biostatistics, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Device landing zone (DLZ) calcification is an important determinant of procedural success in transcatheter aortic valve implantation (TAVI). OBJECTIVE: To evaluate the impact of DLZ calcification on procedural outcome with different types of transcatheter heart valves (THVs). METHODS: Aortic valve calcium density (AVCdens) was determined by non-contrast-enhanced computed tomography in 1232 patients undergoing transfemoral TAVI. We stratified the outcome data according to the extent of AVCdens (mild, moderate, severe) and compared balloon-expandable (BE) with self-expanding (SE) THV. Moreover, THVs were subdivided according to their radial force (BE: high; SEmod: moderate; SElow: low). RESULTS: With BE THV, PVR ≥2° (2.1 vs. 7.9%; p < 0.001), post-dilatation (12.3 vs. 36.6%; p < 0.001), malpositioning (8.4 vs. 13.0%; p = 0.01), device embolization (0.4 vs. 2.6%; p = 0.004), and the need for a second valve (1.2 vs. 3.6%; p = 0.01) were less frequent than with SE devices, but mean transaortic gradients at discharge were higher [12.0 mmHg (8.0-15.0) vs. 9.0 mmHg (6.0-11.0); p < 0.001], and aortic root injury was more frequent (2.7 vs. 0.8%; p = 0.01). In cases of severe calcification, differences between BE and SE THV regarding PVR, post-dilatation, and hemodynamics were mostly pronounced, followed by patients with moderate AVCdens. In cases with low AVCdens, the best outcomes with respect to PVR, pacemaker implantation, and hemodynamics were achieved with SElow THV. CONCLUSIONS: In severe and moderate DLZ calcification, BE devices may have advantages, whereas in mild DLZ calcification, SElow THV showed the most favorable profile.
BACKGROUND: Device landing zone (DLZ) calcification is an important determinant of procedural success in transcatheter aortic valve implantation (TAVI). OBJECTIVE: To evaluate the impact of DLZ calcification on procedural outcome with different types of transcatheter heart valves (THVs). METHODS: Aortic valve calcium density (AVCdens) was determined by non-contrast-enhanced computed tomography in 1232 patients undergoing transfemoral TAVI. We stratified the outcome data according to the extent of AVCdens (mild, moderate, severe) and compared balloon-expandable (BE) with self-expanding (SE) THV. Moreover, THVs were subdivided according to their radial force (BE: high; SEmod: moderate; SElow: low). RESULTS: With BE THV, PVR ≥2° (2.1 vs. 7.9%; p < 0.001), post-dilatation (12.3 vs. 36.6%; p < 0.001), malpositioning (8.4 vs. 13.0%; p = 0.01), device embolization (0.4 vs. 2.6%; p = 0.004), and the need for a second valve (1.2 vs. 3.6%; p = 0.01) were less frequent than with SE devices, but mean transaortic gradients at discharge were higher [12.0 mmHg (8.0-15.0) vs. 9.0 mmHg (6.0-11.0); p < 0.001], and aortic root injury was more frequent (2.7 vs. 0.8%; p = 0.01). In cases of severe calcification, differences between BE and SE THV regarding PVR, post-dilatation, and hemodynamics were mostly pronounced, followed by patients with moderate AVCdens. In cases with low AVCdens, the best outcomes with respect to PVR, pacemaker implantation, and hemodynamics were achieved with SElow THV. CONCLUSIONS: In severe and moderate DLZ calcification, BE devices may have advantages, whereas in mild DLZ calcification, SElow THV showed the most favorable profile.
Authors: Carl Schultz; Alexia Rossi; Nicolas van Mieghem; Robert van der Boon; Stella-Lida Papadopoulou; Ron van Domburg; Adriaan Moelker; Nico Mollet; Gabriel Krestin; Robert-Jan van Geuns; Koen Nieman; Pim de Feyter; Patrick W Serruys; Peter de Jaegere Journal: EuroIntervention Date: 2011-09 Impact factor: 6.534
Authors: Neil E Moat; Peter Ludman; Mark A de Belder; Ben Bridgewater; Andrew D Cunningham; Christopher P Young; Martyn Thomas; Jan Kovac; Tom Spyt; Philip A MacCarthy; Olaf Wendler; David Hildick-Smith; Simon W Davies; Uday Trivedi; Daniel J Blackman; Richard D Levy; Stephen J D Brecker; Andreas Baumbach; Tim Daniel; Huon Gray; Michael J Mullen Journal: J Am Coll Cardiol Date: 2011-10-20 Impact factor: 24.094
Authors: Ganesh Athappan; Eshan Patvardhan; E Murat Tuzcu; Lars Georg Svensson; Pedro A Lemos; Chiara Fraccaro; Giuseppe Tarantini; Jan-Malte Sinning; Georg Nickenig; Davide Capodanno; Corrado Tamburino; Azeem Latib; Antonio Colombo; Samir R Kapadia Journal: J Am Coll Cardiol Date: 2013-04-16 Impact factor: 24.094
Authors: Omar K Khalique; Rebecca T Hahn; Hemal Gada; Tamim M Nazif; Torsten P Vahl; Isaac George; Bindu Kalesan; Molly Forster; Mathew B Williams; Martin B Leon; Andrew J Einstein; Todd C Pulerwitz; Gregory D N Pearson; Susheel K Kodali Journal: JACC Cardiovasc Interv Date: 2014-08 Impact factor: 11.195
Authors: Lutz Buellesfeld; Stefan Stortecky; Dik Heg; Steffen Gloekler; Bernhard Meier; Peter Wenaweser; Stephan Windecker Journal: EuroIntervention Date: 2014-10 Impact factor: 6.534
Authors: Alexander W Leber; Markus Kasel; Thomas Ischinger; Ulrich H Ebersberger; Diethmar Antoni; Martin Schmidt; Gotthard Riess; Vivian Renz; Armin Huber; Thomas Helmberger; Ellen Hoffmann Journal: Int J Cardiol Date: 2011-12-22 Impact factor: 4.164
Authors: Marco Barbanti; Tae-Hyun Yang; Josep Rodès Cabau; Corrado Tamburino; David A Wood; Hasan Jilaihawi; Phillip Blanke; Raj R Makkar; Azeem Latib; Antonio Colombo; Giuseppe Tarantini; Rekha Raju; Ronald K Binder; Giang Nguyen; Melanie Freeman; Henrique B Ribeiro; Samir Kapadia; James Min; Gudrun Feuchtner; Ronen Gurtvich; Faisal Alqoofi; Marc Pelletier; Gian Paolo Ussia; Massimo Napodano; Fabio Sandoli de Brito; Susheel Kodali; Bjarne L Norgaard; Nicolaj C Hansson; Gregor Pache; Sergio J Canovas; Hongbin Zhang; Martin B Leon; John G Webb; Jonathon Leipsic Journal: Circulation Date: 2013-06-07 Impact factor: 29.690
Authors: Maksymilian P Opolski; Won-Keun Kim; Christoph Liebetrau; Claudia Walther; Johannes Blumenstein; Luise Gaede; Jörg Kempfert; Arnaud Van Linden; Thomas Walther; Christian W Hamm; Helge Möllmann Journal: Clin Res Cardiol Date: 2015-01-06 Impact factor: 5.460
Authors: Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb Journal: N Engl J Med Date: 2016-04-02 Impact factor: 91.245
Authors: Tobias Rheude; Costanza Pellegrini; Jonathan Michel; Christian Thilo; Michael Joner; Albert Markus Kasel Journal: Clin Res Cardiol Date: 2018-06-13 Impact factor: 5.460
Authors: Masahiko Asami; Thomas Pilgrim; Stefan Stortecky; Dik Heg; Eva Roost; Stephan Windecker; Lukas Hunziker Journal: Clin Res Cardiol Date: 2019-03-30 Impact factor: 5.460
Authors: Sven Thomas Niepmann; Eva Steffen; Andreas Zietzer; Matti Adam; Julia Nordsiek; Isabella Gyamfi-Poku; Kerstin Piayda; Jan-Malte Sinning; Stephan Baldus; Malte Kelm; Georg Nickenig; Sebastian Zimmer; Christine Quast Journal: Clin Res Cardiol Date: 2019-02-14 Impact factor: 5.460
Authors: Helge Möllmann; Oliver Husser; Johannes Blumenstein; Christoph Liebetrau; Oliver Dörr; Won-Keun Kim; Holger Nef; Christian Tesche; Christian W Hamm; Albrecht Elsässer; Stephan Achenbach; Luise Gaede Journal: Clin Res Cardiol Date: 2019-10-01 Impact factor: 5.460